Axis Wins, Avigilon Tripwire Patent Annulled

By John Honovich, Published Feb 06, 2019, 10:17am EST

For approaching a decade, the fundamental Object Video tripwire patent has been at the core of an industry debate over patenting and video analytic usage. Now, that patent (acquired by Avigilon a few years ago) has been annulled as Axis / Canon's petition to invalidate the tripwire patent has been granted.

Inside this note, we examine the overall legal battle between Avigilon and Axis, how this was annulled and what impact it has for the industry.

Annulled ******

*** ********* ****** *** '***** tripwire' *** **** ******** ** a*** *, **** ******** (see ****** ******), ************ *****:

*** ***** *** ********** is **** * ******* named *********, ** ***** traffic ********** ****** **** used ***** ********* ********* tripwires *** ***********.

Central ******

**** **** ** ****,**** *********** ***** **** Bosch, *******, *** ****, **** ********* ****** *** ** *** core ** *** **********. The ****** ***** ** that *** ****** ** so *********** ** ****** any ***** ******** ****** as ** ******* *********** (both ********* *** ******) as **** ** ********* which *** ********* **** to *********** ******** ********* from ****** ****** ** an ****** *****.

Ongoing **** / ******** ******

***** **** ** * significant ***** ** ******, this ** **** ** a ****** ***** ****** between ******** *** **** (and **** ****** *****).** ****, ***** **** Avigilon *** ****** ************. ***, **** ** the **** * *****,**** ***** ** ********** 4 ******** *******, ********* **** *** that *** ****** ***** just ********. ** *** same ****, ******** **** Axis *** ********* ** NDA.

*** ** **** *** seem * *** *********. However,******** ******** ****** *****'* patents ** **** *** $80 *******, *********** ********** ***********'* ************* patent ********* ******** ***** Avigilon's **** *** *** as * ***** ** boost *******. ***** *** questions ** *** *******' validity (** *** ** patents **** ** ** granted ******* *** *** frequently ********** ** * petition ** **** *** done ****), **** ********** are ***** ****** **********.

Impact ** ******** ****** *********

********** **** *** ********** of (** *****) ******** hype, ********* **** ****** eliminates * ***** ******* for ********* ******** **** they *** *** ********* Avigilon's *******. **** *** most ********* * ******* for **** ** **** a *** ****** ****** area ** ******* / tolled ** * ***** competitor.

**** **** *** *** Avigilon's ****** *********, ******, by *** *****. ******** still *** **** ************ ** ***** ********* program, ****** ******** *** tripwire *** *** *** most ********.

****, ** ******* ** not **** *******. *** tripwire patent *** **** *** 2000s **, ** **** point ** *** **** few *****, *** ****** would **** ****** ******* (though **** ** ****** be ******* ***** ******* of ****** ***).

Adds ** ******* ************

**** ** *** ****** time ** * **** that **** *** *** a ****** ****-*** **** a **********. ** ******** 2018,******* ********* ************ ** their **** *****-****** ****** after *********** * ******* ****** of ************ **** ******.

Axis / ******** ******** *******

**** **** *** ******** declined ** ******* ** IPVM ** *** ******.

Comments (15)

....******** ******** ****** *****'* patents ** **** *** $80 *******...******** *** ******** one *** *** **** valuable.

*** ******** **** *** Street?

***** ********* *** ******** *** ******* stock ********? * ***'* get **. ******** ** no ****** * ******** traded ******* ** ** was ******** ** ******** Solutions ***** ****** ** the ****.

***, ****** :(

*** ******** ********* ** a ***** ****** ******* with * ******* ** businesses **** **** ** effectively **********. *******, *** the ***** ************ ********* market, ** ** ********.

***...***** ** *** :)))

******** **** *** ****** for ****** ** *** fight.  ******* ****** **********.

******* ****** **********.

**** ***** *** ********. I *** *** *** a ************.  **** **** firm *** **** **** patents ** ****?  **** certainly ****.  **** * feel stifles ********** ** *** horrible ****** ****** ** play ** *** **, the ******* **** ** abuse **, *** *** sheer ****** ** ******* that **** ** ***** companies *****.  *'* *** saying ******** *** ** abuser ** *** - I ****** ***'* ****.  ObjectVideo *** ********** * patent ***** ** *** end.

****: * *** *** vote *** ********.

**** **** **** *** have **** ******* ** play? **** ********* ****

**** ********* **** ******* use **** *********** ****** than ***********. **** *** the ***** **** **, that ** ****** **** weapon.

*** ** * ***'* entirely ***** **** "******* stifle **********" *** * do ***** **'* **** to *** **** ****** broad ******* ** ******* that *** ******* ******* without ****** *********** ******** prior *** *** * problem.

*******! ******* ****** ** a ****** ** ******* IP, *** * ******.

******* *** *** ****** that ********** *** ********* to ********. *** *** come ** **** *** next ***-**** *****. ** there **** ** *******, then *** ***** **** instant *********** **** **** has *** **** ***-**** thing **** **** ****** from ******* *** **** pesky ****** *** **********. That's ** ************** ****, but **** ******* ** also **************.   

**

* *** ****, ** a *** *******?

**'* * ****** ***** subsidiary **** * ******* holds ***** ****** *********. It ** *********, *.*.,** **** ******** ********* report.

* ** ******** ***** is **** **** ** legal ****** ** ** so *** **'* ************* a **** ** ********.

** **** ***, *** at **** ****? ** the ******* ****** ***, the ****** ** *** to ****** ****. *** much *** ***** ****** to ********** **** *** patent, *** **** ******* did **** **** ** have ** *** ** license ****? ***** **** endure **** ********** *** expensive ****** *****? ** I **** *******, * may ***** ********* ***** after ****** *** ****** of ****** ****, "* wish ** ***** **** them ******* ** *** same *****..." 

***** **** ****** **** protracted *** ********* ****** again?

*** ***** ** **** to **** **** **** a ****** ******. ******** now *** ** ** concerned ***** **** **** is ******* ** ** to ********'* ***** *******.

****, **** ** ****, Axis **** **** **** a ******* ******* ** revenue ** **** **** the ***** ***** ** may ** ***** ******** $100,000 ** ********** **** patent ** **** **** on ****** *********.

**** **** **** *** same ***** **** ***** parent ******* **** *** discussed ******* ** ********* to ********/********? **** ***** have *** ***** *** blood **** ******** *****'*? Honest ********, ******* **** are ****** ***** ************.

Read this IPVM report for free.

This article is part of IPVM's 6,746 reports, 909 tests and is only available to members. To get a one-time preview of our work, enter your work email to access the full article.

Already a member? Login here | Join now
Loading Related Reports